Lupin Atlantis Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LUPIN ATLANTIS, and what generic and branded alternatives to LUPIN ATLANTIS drugs are available?
LUPIN ATLANTIS has one approved drug.
Summary for Lupin Atlantis
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
| Patent Litigation for Lupin Atlantis: | See patent lawsuits for Lupin Atlantis |
Drugs and US Patents for Lupin Atlantis
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lupin Atlantis | ALLERNAZE | triamcinolone acetonide | SPRAY, METERED;NASAL | 020120-001 | Feb 4, 2000 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
